When asked what are the chances that an individual, who is sick and in their 60s, could get monoclonal antibody therapy, US Food and Drug Administration Commissioner Dr. Stephen Hahn told CNN's Dr. Sanjay Gupta that this therapy should be available to them, and they should contact their health care provider about obtaining the therapy.
"The monoclonal antibodies we've authorized seem to work best for preventing hospitalization in outpatients early in their disease – typically within 10 days of the onset of symptoms, if you are a high-risk individual. So, over the age of 65, or over the age of 55 with a comorbidity, or, you know, some preexisting illness to put you at risk – these antibodies, for the last month since authorization, have been distributed around the country. So, they should be available locally, and it's under state jurisdiction," Hahn said.
"So, I would encourage anyone who might be in the categories I described to talk to their provider about this, because as an outpatient, these can be infused to those folks who are in high-risk populations. We know that the clinical endpoint is prevention of hospitalization. ... God knows the health care systems are significantly overstressed at this point, so I would encourage your viewers to ask the providers about this."
Additionally, Hahn underscored that they shouldn't be given to people who are inpatients because there's a suggestion that they may not actually help, but instead be harmful to those who are sicker with Covid-19 and, confirmed to CNN that the FDA is working hard with the manufacturers to make more available.